108 related articles for article (PubMed ID: 28440981)
1. [Leading causes of death during the induction therapy in pediatric patients with acute lymphoblastic leukemia].
Aguilar-Hernández M; Fernández-Castillo G; Núñez-Villegas NN; Pérez-Casillas RX; Núñez-Enríquez JC
Rev Med Inst Mex Seguro Soc; 2017; 55(3):286-291. PubMed ID: 28440981
[TBL] [Abstract][Full Text] [Related]
2. Death analysis of childhood acute lymphoblastic leukaemia; experience at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan.
Asim M; Zaidi A; Ghafoor T; Qureshi Y
J Pak Med Assoc; 2011 Jul; 61(7):666-70. PubMed ID: 22204242
[TBL] [Abstract][Full Text] [Related]
3. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
4. Prednisolone Prophase for a Week Versus Upfront Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia: An Analysis With Reference to Induction Mortality in a Developing Country.
Jabbar N; Mansoor N; Nadeem K; Maqsood MSc S; Butt Z; Ashraf S
J Pediatr Hematol Oncol; 2020 Apr; 42(3):181-184. PubMed ID: 31688627
[TBL] [Abstract][Full Text] [Related]
5. Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience.
Slats AM; Egeler RM; van der Does-van den Berg A; Korbijn C; Hählen K; Kamps WA; Veerman AJ; Zwaan CM
Leukemia; 2005 Apr; 19(4):537-44. PubMed ID: 15690069
[TBL] [Abstract][Full Text] [Related]
6. Identifying causes of variability in outcomes in children with acute lymphoblastic leukemia treated in a resource-rich developing country.
Jastaniah W; Elimam N; Abdalla K; Iqbal BA; Khattab TM; Felimban S; Abrar MB
Pediatr Blood Cancer; 2015 Jun; 62(6):945-50. PubMed ID: 25557583
[TBL] [Abstract][Full Text] [Related]
7. [Results of treatment of acute lymphoblastic leukemia in two cohorts of Mexican patients].
Ramos C; Rozen E; León M; Martínez T A; Olarte I; Catellanos H; Martínez C; Montaño E; Kassack I J; Zamora J; Miranda E; De la Ros A; Gutiérrez M; Collazo J
Rev Med Chil; 2011 Sep; 139(9):1135-42. PubMed ID: 22215391
[TBL] [Abstract][Full Text] [Related]
8. Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
Mejía-Arangure JM; Fajardo-Gutíerrez A; Bernáldez-Ríos R; Rodríguez-Zepeda MC; Espinoza-Hernández L; Martínez-García MC
Arch Med Res; 1997; 28(2):273-9. PubMed ID: 9204621
[TBL] [Abstract][Full Text] [Related]
9. Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group.
Prucker C; Attarbaschi A; Peters C; Dworzak MN; Pötschger U; Urban C; Fink FM; Meister B; Schmitt K; Haas OA; Gadner H; Mann G;
Leukemia; 2009 Jul; 23(7):1264-9. PubMed ID: 19212332
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Socioeconomic Factors on the Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) Treatment in a Low/Middle Income Country (LMIC).
Jabeen K; Ashraf MS; Iftikhar S; Belgaumi AF
J Pediatr Hematol Oncol; 2016 Nov; 38(8):587-596. PubMed ID: 27467375
[TBL] [Abstract][Full Text] [Related]
11. Early mortality in children with acute lymphoblastic leukemia in a developing country: the role of malnutrition at diagnosis. A multicenter cohort MIGICCL study.
Martín-Trejo JA; Núñez-Enríquez JC; Fajardo-Gutiérrez A; Medina-Sansón A; Flores-Lujano J; Jiménez-Hernández E; Amador-Sanchez R; Peñaloza-Gonzalez JG; Alvarez-Rodriguez FJ; Bolea-Murga V; Espinosa-Elizondo RM; de Diego Flores-Chapa J; Pérez-Saldivar ML; Rodriguez-Zepeda MD; Dorantes-Acosta EM; Núñez-Villegas NN; Velazquez-Aviña MM; Torres-Nava JR; Reyes-Zepeda NC; González-Bonilla CR; Flores-Villegas LV; Rangel-López A; Rivera-Luna R; Paredes-Aguilera R; Cárdenas-Cardós R; Martínez-Avalos A; Gil-Hernández AE; Duarte-Rodríguez DA; Mejía-Aranguré JM
Leuk Lymphoma; 2017 Apr; 58(4):898-908. PubMed ID: 27561220
[TBL] [Abstract][Full Text] [Related]
12. Treating childhood acute lymphoblastic leukemia in a developing country 1998-2003: the experience of a single children's hospital in China.
Gao YJ; Lu FJ; Wang HS
J Pediatr Hematol Oncol; 2006 Dec; 28(12):798-802. PubMed ID: 17164648
[TBL] [Abstract][Full Text] [Related]
13. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
14. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
Wei W; Chen X; Zou Y; Chang L; An W; Wan Y; Liu T; Yang W; Chen Y; Guo Y; Zhu X
BMC Pediatr; 2015 Jul; 15():80. PubMed ID: 26174476
[TBL] [Abstract][Full Text] [Related]
15. [Leukemia and malnutrition. II. The magnitude of maintenance chemotherapy as a prognostic factor in the survival of patients with standard-risk acute lymphoblastic leukemia].
Lobato-Mendizábal E; Ruiz-Argüelles GJ
Rev Invest Clin; 1990; 42(2):81-7. PubMed ID: 2267453
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and induction outcome of childhood acute lymphoblastic leukemia in a lower/middle income population: A multi-institutional report from Pakistan.
Fadoo Z; Nisar I; Yousuf F; Lakhani LS; Ashraf S; Imam U; Zaheer J; Naqvi A; Belgaumi A
Pediatr Blood Cancer; 2015 Oct; 62(10):1700-8. PubMed ID: 25982135
[TBL] [Abstract][Full Text] [Related]
17. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
18. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
19. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001.
Christensen MS; Heyman M; Möttönen M; Zeller B; Jonmundsson G; Hasle H;
Br J Haematol; 2005 Oct; 131(1):50-8. PubMed ID: 16173962
[TBL] [Abstract][Full Text] [Related]
20. [Failure of treatment and protocol compliance in patients with acute lymphoblastic leukemia].
Tang JY; Xue HL; Gu LJ; Chen J; Pan C; Chen J; Wang YP; Ye H; Dong L; Zou JY
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):490-3. PubMed ID: 16083545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
